EMYRIA LIMITED — Capital/Financing Update 2020

Feb 9, 2020

ASX/Media Release

==> picture [170 x 82] intentionally omitted <==

6/02/2020

Capital Structure and Escrowed Securities

Perth, Australia; 6 February 2020: Emerald Clinics Limited (ASX:EMD) advises that upon listing its capital structure and escrowed securities will be as follows:

CAPITAL STRUCTURE

	Ordinary	Unlisted Options
	Shares
Ordinary Shares	183,902,778
Unlisted Options exercisable at $0.45on or before 13 June		17,750,000
2023
Unlisted Options exercisable at $0.45on or before 26		600,000
September 2023
On issue at date of re-quotation	183,902,778	18,350,000

RESTRICTED SECURITIES

	Ordinary		Unlisted Options
	Shares
Ordinary Shares – 24 Months from re- quotation	100,097,478		-
Unlisted Options exercisable at $0.45 on or before 13 June	-		10,500,000
2023 – 24 Months from re-quotation
Unlisted Options exercisable at $0.45 on or before 13 June		-	5,250,000
2023 – 13 June 2020
Unlisted Options exercisable at $0.45 on or before 13 June		-	600,000
2023 – 26 September 2020
Unlisted Options exercisable at $0.45 on or before 13 June		-	1,000,000
2023 – 24 October 2020
Unlisted Options exercisable at $0.45 on or before 13 June		-	1,000,000
2023 – 11 November 2020
	100,097,478		18,350,000

Company Secretary

Simon Robertson

==> picture [169 x 82] intentionally omitted <==

About Emerald Clinics Limited

Emerald Clinics Limited (ACN 625 085 734) is an Australian incorporated company that operates a network of specialist medical clinics (Clinics) and uses purpose-built software and technology to gather high quality clinical data from informed and consenting patients.

Emerald is a clinical services and healthcare technology company focussed on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines. In addition, Emerald uses technology to capture clinical data that can be used to generate clinical evidence relating to the safety and efficacy of unregistered medicines.

Emerald has established four medical centres in Australia including one site each in West Leederville WA, Woolloomooloo NSW, Tintenbar NSW and Richmond VIC.

For more information, please contact:

General enquiries Investor and Media enquiries Emerald Clinics Limited Matthew Wright P: +61 8 6559 2800 NWR Communications admin@emeraldclinics.com.au matt@nwrcommunications.com.au

Cautionary Note on Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for the Company, the company’s strategy, future operations, and other statements containing the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar expressions, constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a results of various important factors, including: the Company’s ability to successfully develop its product candidates and timely complete its planned clinical programs and the Company’s ability to obtain marketing approvals for its product candidates. In addition, the forward-looking statements included in this press release represents the Company’s views as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forwardlooking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date hereof.